RxDoctor Payments Data

Iris Danziger, MD

Otolaryngology · West Seneca, NYNPI 1902887102

Payments from drug & device makers

$947in general payments, 2019–2025

Across 10 payments — averaging $94.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$220
  • Aerin Medical Inc.$144
  • Sanofi$125
  • GSK$125
  • Acclarent, Inc$123
  • Intersect ENT, Inc.$106
  • plus $105 from 2 others

What the payments were for

  • Food & beverage$947100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew2$220
Aerin Medical Inc.1$144
Sanofi1$125
GSK1$125
Acclarent, Inc1$123
Intersect ENT, Inc.2$106
Stryker1$89
Gilead1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$947 in reported general payments places this provider in the 45th percentile of 701 otolaryngology providers in New York.

See all otolaryngology providers in New York

Medicare billing

Part B allowed, 2024
$63,870
Medicare patients
297
Services billed
772

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide147$6,484
Fluticasone Propionate144$3,156
Ofloxacin92$2,910
Azelastine Hcl91$2,715
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort45$2,610
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort18$2,316
SynthroidLevothyroxine Sodium28$1,922
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth13$1,463
Prednisolone Acetate17$1,406
Levothyroxine Sodium95$1,284
Glycopyrrolate24$756
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav61$663
Montelukast Sodium32$446
Meclizine Hcl38$373
Methylprednisolone42$302

Paid to pharmacies, not to this prescriber.

Other otolaryngology in West Seneca

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →